{"id":51214,"date":"2022-11-24T01:02:45","date_gmt":"2022-11-24T00:02:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/"},"modified":"2022-11-24T01:02:45","modified_gmt":"2022-11-24T00:02:45","slug":"foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/","title":{"rendered":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022"},"content":{"rendered":"
\n

MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc.<\/a> (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that the Company has filed its Form 10-Q for the third quarter ended September 30, 2022.\n<\/p>\n

<\/a><\/p>\n

\nThe company initially delayed its filing of Form 10-Q for the third quarter of 2022, which was originally expected on November 14, 2022, to review the accounting treatment of certain warrants and Series A Preferred Stock. The Company concluded the accounting treatment was appropriate and timely filed the Form 10-Q within the extension period.\n<\/p>\n

\n\u201c2022 has been a year full of challenges, a year both momentous and extraordinary,\u201d said Tyler Danielson, interim CEO and Chief Technologies Officer of FOXO Technologies. \u201cWe have withstood challenging macro conditions, an interesting life insurance market as well as a market downturn. Facing the complex dynamics, FOXO has managed to build out our first release of the Longevity Report, configured an automated epigenetic testing system, and worked on integrations to our partner’s systems of which we have two. We continue to focus on building a strong technical foundation. We are building this in such a way that quality, adaptability, and speed to market are our core tenants. With this strong base, we will be able to quickly adapt to our consumer’s expectations of great user experience as well as work with our partners and their differing and changing technologies. All the while we continue to innovate on our technologies that support epigenetic testing and the automation of our internal systems which are helping move the science forward. As a company that is still very much a startup in many ways, we have a lot of goals we want to achieve in the near future that might require us to evolve or pivot. We continue to evaluate our internal hypotheses to know what we are building for our market is what makes our customers the most satisfied. With access to many more agents, great partnerships, and amazing technology I feel confident in the value we will provide to our shareholders.\u201d\n<\/p>\n

\nAs a result of its delayed filing, the company has decided to forego its previously planned third quarter 2022 earnings and business update call and will instead look to host a fourth quarter 2022 earnings and business update call at a later date. The Company will communicate details when appropriate.\n<\/p>\n

\nAbout FOXO Technologies Inc. (\u201cFOXO\u201d)<\/b>\n<\/p>\n

\nFOXO is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO’s epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO seeks to modernize the life insurance industry by simplifying the consumer underwriting journey with saliva-based biomarkers and enhancing life insurance\u2019s consumer value proposition with the FOXO Longevity Report\u2122<\/span>. For more information about FOXO, visit www.foxotechnologies.com<\/a>. For more information about FOXO LIFE, visit www.foxolife.com<\/a>. For investor information and updates, visit https:\/\/foxotechnologies.com\/investors\/<\/a>.\n<\/p>\n

\nNo Offer or Solicitation<\/b>\n<\/p>\n

\nThis communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended or an exemption therefrom.\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains certain forward-looking statements for purposes of the \u201csafe harbor\u201d provisions under the United States Private Securities Litigation Reform Act of 1995. Any statements other than statements of historical fact contained herein, including statements as to future results of operations and financial position, planned products and services, business strategy and plans, objectives of management for future operations of FOXO, market size and growth opportunities, competitive position and technological and market trends, are forward-looking statements. Such forward-looking statements include, but not limited to, expectations, hopes, beliefs, intentions, plans, prospects, financial results or strategies regarding FOXO and the future held by management teams of FOXO, the future financial condition and performance of FOXO and the products and markets and expected future performance and market opportunities of FOXO. These forward-looking statements generally are identified by the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccould,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cstrategy,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cstrategy,\u201d \u201copportunity,\u201d \u201cplan,\u201d project,\u201d \u201cpossible,\u201d \u201cpotential,\u201d \u201cproject,\u201d \u201cpredict,\u201d \u201cscales,\u201d \u201crepresentative of,\u201d \u201cvaluation,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cwill be,\u201d \u201cwill continue,\u201d \u201cwill likely result,\u201d and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) the risk of changes in the competitive and highly regulated industries in which FOXO operates, variations in operating performance across competitors or changes in laws and regulations affecting FOXO\u2019s business, (ii) the ability to implement FOXO\u2019s business plans, forecasts, and other expectations, (iii) the ability to obtain financing if needed, (iv) the ability to maintain its NYSE American listing, (v) the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future, (vi) potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans, (vii) the enforceability of FOXO\u2019s intellectual property, including its patents and the potential infringement on the intellectual property rights of others, and (viii) the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO\u2019s prospective customers operate, including the highly regulated insurance industry. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in the Registration Statement on Form S-4, under the heading \u201cRisk Factors,\u201d and other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nFOXO TECHNOLOGIES INC. AND SUBSIDIARIES<\/b>\n<\/p>\n

\nCONSOLIDATED BALANCE SHEETS<\/b>\n<\/p>\n

\n(Dollars in thousands, except per share data)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

\nSeptember 30,<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\nDecember 31,<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

\n2022<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2021<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAssets<\/b>\n<\/p>\n<\/td>\n

\n

\n(unaudited)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nCurrent assets\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nCash and cash equivalents\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n10,454\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n6,856\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nSupplies\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,057\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n295\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPrepaid expenses\n<\/p>\n<\/td>\n

<\/td>\n\n

\n511\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n444\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPrepaid consulting fees\n<\/p>\n<\/td>\n

<\/td>\n\n

\n4,758\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nOther current assets\n<\/p>\n<\/td>\n

<\/td>\n\n

\n20\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n23\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal current assets<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n17,800<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n7,618<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nProperty and equipment, net\n<\/p>\n<\/td>\n

<\/td>\n\n

\n136\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n187\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nIntangible assets\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,071\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n191\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nInvestments\n<\/p>\n<\/td>\n

<\/td>\n\n

\n100\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n100\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nReinsurance recoverables\n<\/p>\n<\/td>\n

<\/td>\n\n

\n18,754\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,463\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCloud computing arrangements\n<\/p>\n<\/td>\n

<\/td>\n\n

\n4,709\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n2,745\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase collateral\n<\/p>\n<\/td>\n

<\/td>\n\n

\n27,919\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal assets<\/b>\n<\/p>\n<\/td>\n

\n

\n$<\/b>\n<\/p>\n<\/td>\n

\n

\n71,489<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$<\/b>\n<\/p>\n<\/td>\n

\n

\n30,304<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nLiabilities and Stockholders’ Equity<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nCurrent liabilities\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nAccounts payable\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n2,706\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n3,456\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nRelated party payable\n<\/p>\n<\/td>\n

<\/td>\n\n

\n500\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nShares payable\n<\/p>\n<\/td>\n

<\/td>\n\n

\n384\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nParallel run advance\n<\/p>\n<\/td>\n

<\/td>\n\n

\n256\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccrued and other liabilities\n<\/p>\n<\/td>\n

<\/td>\n\n

\n504\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n402\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase put derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,284\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase collateral derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n27,378\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nRelated party convertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n9,967\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nConvertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n22,236\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal current liabilities<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n33,012<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n36,061<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWarrant liability\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,038\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nLong term debt\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,918\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPolicy reserves\n<\/p>\n<\/td>\n

<\/td>\n\n

\n18,754\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,463\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal liabilities<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n55,722<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n55,524<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCommitments and contingencies (Note 13)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nStockholders’ equity (deficit)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nPreferred stock, $0.0001 par value; 10,000,000 shares authorized, none issued or outstanding as of September 30, 2022\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nClass A common stock, $0.0001 par value, 500,000,000 shares authorized, 33,027,830 issued and outstanding as of September 30, 2022\n<\/p>\n<\/td>\n

<\/td>\n\n

\n3\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nUndesignated preferred stock, $.00001 par value; 90,000,000 shares authorized, none issued and outstanding as of December 31, 2021)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNon-redeemable preferred stock series A, $.00001 par value; 10,000,000 shares authorized, 8,000,000 shares issued and outstanding as of December 31, 2021\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n21,854\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCommon stock class A, $.00001 par value; 800,000,000 shares authorized; 30,208 shares issued and outstanding as of December 31, 2021)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCommon stock class B, $.00001 par value, 100,000,000 shares authorized; 2,000,000 shares issued and outstanding as of December 31, 2021)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAdditional paid-in capital\n<\/p>\n<\/td>\n

<\/td>\n\n

\n144,672\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n4,902\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccumulated deficit\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(128,908\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(51,976\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal stockholders’ equity (deficit)<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n15,767<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(25,220<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal Liabilities and Stockholders’ Equity (Deficit)<\/b>\n<\/p>\n<\/td>\n

\n

\n$<\/b>\n<\/p>\n<\/td>\n

\n

\n71,489<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$<\/b>\n<\/p>\n<\/td>\n

\n

\n30,304<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nFOXO TECHNOLOGIES INC. AND SUBSIDIARIES<\/b>\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF OPERATIONS<\/b>\n<\/p>\n

\n(Dollars in thousands, except per share data)\n<\/p>\n

\n(Unaudited)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

\nThree Months Ended
\n
September 30,<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\nNine Months Ended
\n
September 30,<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

\n2022<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n2021<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n2022<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n2021<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nTotal revenue<\/b>\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n14<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n31<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n93<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n93<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nOperating expenses:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nResearch and development\n<\/p>\n<\/td>\n

<\/td>\n\n

\n558\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,665\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n2,160\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n4,321\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nSelling, general and administrative\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n8,269\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n2,721\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n17,239\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n7,640\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal operating expenses\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n8,827\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n4,386\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n19,399\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n11,961\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nLoss from operations<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(8,813<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(4,355<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(19,306<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(11,868<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNon-cash change in fair value of convertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(3,697\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(22,571\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(28,180\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(24,890\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of warrant liability\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,349\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,349\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of forward purchase put derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,284\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(1,284\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of forward purchase collateral derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(27,378\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(27,378\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nOther expense\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(779\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(2\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(883\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(31\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nInterest expense\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(424\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(313\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(1,250\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(825\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTotal other expense\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(32,213\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(22,886\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(57,626\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(25,746\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nLoss before income taxes<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(41,026<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(27,241<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(76,932<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(37,614<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nProvision for income taxes\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNet loss<\/b>\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n(41,026<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(27,241<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(76,932<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(37,614<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nNet loss per Class A common stock, basic and diluted\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n(6.70\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(4.68\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(12.88\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(6.47\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nFOXO TECHNOLOGIES INC. AND SUBSIDIARIES<\/b>\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 DEFICIT\n<\/p>\n

\n(Dollars in thousands)\n<\/p>\n

\n(Unaudited)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nFOXO Technologies Operating Company<\/b><\/td>\n<\/td>\n<\/td>\nFOXO Technologies Inc.<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\nStockholder Subscription Receivable<\/b><\/td>\n<\/td>\nSeries A Preferred Stock<\/b><\/td>\n<\/td>\nCommon Stock (Class A)<\/b><\/td>\n<\/td>\nCommon Stock (Class B)<\/b><\/td>\n<\/td>\n<\/td>\nCommon Stock (Class A)<\/b><\/td>\n<\/td>\nAdditional Paid-in-Capital<\/b><\/td>\n<\/td>\nAccumulated Deficit<\/b><\/td>\n<\/td>\nTotal<\/b><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/td>\nShares<\/b><\/td>\n<\/td>\nAmount<\/b><\/td>\n<\/td>\nShares<\/b><\/td>\n<\/td>\nAmount<\/b><\/td>\n<\/td>\nShares<\/b><\/td>\n<\/td>\nAmount<\/b><\/td>\n<\/td>\n<\/td>\nShares<\/b><\/td>\n<\/td>\nAmount<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Three Months Ended September 30, 2021<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Balance, June 30, 2021<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n(1,250<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n30,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n4,447<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(23,861<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n1,190<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(27,241\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(27,241\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Lease contributions<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n137\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n137\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n45\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n45\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Subscriptions received<\/td>\n<\/td>\n<\/td>\n\n

\n1,250\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,250\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Balance, September 30, 2021<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n30,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n4,629<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(51,102<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(24,619<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
Nine Months Ended September 30, 2021<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Balance, December 31, 2020<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n(3,750<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n4,104<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(13,488<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n8,720<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(37,614\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(37,614\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Lease contributions<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n410\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n410\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n102\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n102\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Subscriptions received<\/td>\n<\/td>\n<\/td>\n\n

\n3,750\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n3,750\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Warrants issued<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n13\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n13\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Issuance of shares for restricted stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n30,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Balance, September 30, 2021<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n30,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n4,629<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(51,102<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(24,619<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
Three Months Ended September 30, 2022<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Balance, June 30, 2022<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,545,154<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n12,026<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(87,882<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(54,002<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

Activity prior to the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(9,531\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(9,531\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n211\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n211\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Effects of the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of Series A Preferred Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(8,000,000\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(21,854\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n21,854\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of Bridge Loans<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n15,172,729\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n88,975\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n88,975\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of Class B Common Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(2,000,000\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of existing Class A Common Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(26,717,883\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n15,518,705\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Reverse recapitalization<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n8,143,649\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,677\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,678\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Activity after the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(31,495\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(31,495\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n9,175,000\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n329\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n330\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Cantor Commitment Fee<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n190,476\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,600\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,600\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Balance, September 30, 2022<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n33,027,830<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n3<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n144,672<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(128,908<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n15,767<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
Nine Months Ended September 30, 2022<\/b><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Balance, December 31, 2021<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n21,854<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n30,208<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n4,902<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(51,976<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(25,220<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

Activity prior to the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(45,437\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(45,437\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Lease contributions<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n225\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n225\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n717\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n717\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Warrant repurchase<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(507\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(507\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Issuance of shares for exercised stock options<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n14,946\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Issuance of shares for consulting agreement<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,500,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n6,900\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n6,900\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Effects of the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Conversion of Series A Preferred Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(8,000,000\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(21,854\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n8,000,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n21,854\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of Bridge Loans<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n15,172,729\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n88,975\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n88,975\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of Class B Common Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,000,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(2,000,000\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Conversion of existing Class A Common Stock<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(26,717,883\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n15,518,705\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Reverse recapitalization<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n8,143,649\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,677\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n19,678\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Activity after the business combination:<\/i><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Net loss<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(31,495\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(31,495\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

Equity-based compensation<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n9,175,000\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n329\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n330\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Cantor Commitment Fee<\/td>\n<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n190,476\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,600\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n1,600\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

Balance, September 30, 2022<\/td>\n<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n–<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n33,027,830<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n3<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n144,672<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n(128,908<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n$<\/b><\/td>\n\n

\n15,767<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\nFOXO TECHNOLOGIES INC. AND SUBSIDIARIES<\/b>\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF CASH FLOWS\n<\/p>\n

\n(Dollars in thousands)\n<\/p>\n

\n(Unaudited)\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/tr>\n
<\/td>\n\n

\nNine Months Ended
\n
September 30,<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

\n2022<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n2021<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCASH FLOWS FROM OPERATING ACTIVITIES:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nNet loss\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n(76,932\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n(37,614\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAdjustments to reconcile net loss to net cash used in operating activities:\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nDepreciation\n<\/p>\n<\/td>\n

<\/td>\n\n

\n159\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n71\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nEquity-based compensation\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,002\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n8\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCantor commitment fee\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,600\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAmortization of consulting fees\n<\/p>\n<\/td>\n

<\/td>\n\n

\n2,954\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of convertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n28,180\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n24,890\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of forward purchase agreement collateral derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n27,378\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of warrants\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,349\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChange in fair value of forward purchase agreement put derivative\n<\/p>\n<\/td>\n

<\/td>\n\n

\n1,284\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nConversion of accrued interest\n<\/p>\n<\/td>\n

<\/td>\n\n

\n593\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nContributions in the form of rent payments\n<\/p>\n<\/td>\n

<\/td>\n\n

\n225\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n410\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAmortization of right-of-use assets\n<\/p>\n<\/td>\n

<\/td>\n\n

\n20\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccretion of operating lease liabilities\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(20\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nRecognition of prepaid offering costs upon election of fair value option\n<\/p>\n<\/td>\n

<\/td>\n\n

\n107\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccretion of interest earned on investment in convertible promissory note\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(26\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nOther\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n13\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nChanges in operating assets and liabilities:\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nSupplies\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,762\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(296\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPrepaid expenses, consulting fees, and other current assets\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,002\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n55\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCloud computing arrangements\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,941\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(1,701\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nReinsurance recoverables\n<\/p>\n<\/td>\n

<\/td>\n\n

\n709\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n88\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccounts payable\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(489\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n2,247\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccrued and other liabilities\n<\/p>\n<\/td>\n

<\/td>\n\n

\n761\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n197\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nPolicy reserves\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(709\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(88\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNet cash used in operating activities<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(19,232<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(11,746<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCASH FLOWS FROM INVESTING ACTIVITIES:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nPurchase of property and equipment\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(108\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(73\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAsset acquisition, net of cash acquired\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(63\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDevelopment of internal use software\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,622\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(9\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAcquisition of convertible promissory note\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n(50\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNet cash used in investing activities<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(1,730<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(195<\/b>\n<\/p>\n<\/td>\n

\n

\n)<\/b>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCASH FLOWS FROM FINANCING ACTIVITIES:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nProceeds from issuance of related party convertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n3,250\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nProceeds from issuance of convertible debentures\n<\/p>\n<\/td>\n

<\/td>\n\n

\n28,000\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n7,250\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nWarrant repurchase\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(507\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nSenior PIK Notes proceeds\n<\/p>\n<\/td>\n

<\/td>\n\n

\n3,458\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nReverse recapitalization proceeds\n<\/p>\n<\/td>\n

<\/td>\n\n

\n23,226\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase agreement escrow\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(29,135\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase agreement proceeds\n<\/p>\n<\/td>\n

<\/td>\n\n

\n484\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForward purchase agreement collateral release to Meteora\n<\/p>\n<\/td>\n

<\/td>\n\n

\n733\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDeferred offering costs\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(539\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nRelated party promissory note\n<\/p>\n<\/td>\n

<\/td>\n\n

\n(1,160\n<\/p>\n<\/td>\n

\n

\n)\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nProceeds received from stockholder subscription receivable\n<\/p>\n<\/td>\n

<\/td>\n\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n3,750\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNet cash provided by financing activities<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n24,560<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n14,250<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNet increase in cash and cash equivalents<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\n3,598<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n2,309<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCash and cash equivalents at beginning of period\n<\/p>\n<\/td>\n

<\/td>\n\n

\n6,856\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n\n

\n8,123\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCash and cash equivalents at end of period<\/b>\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n10,454<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n10,432<\/b>\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n

\nNONCASH INVESTING AND FINANCING ACTIVITIES:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\n

\nConversion of phantom equity to stock options\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n54\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nConversion of debt\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n88,382\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nConversion of preferred stock\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n21,854\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccrued internal use software\n<\/p>\n<\/td>\n

\n

\n$\n<\/p>\n<\/td>\n

\n

\n239\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

<\/td>\n\n

\n$\n<\/p>\n<\/td>\n

\n

\n–\n<\/p>\n<\/td>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u00a0\n<\/p>\n

Contacts<\/b> <\/p>\n

\nContacts \/ Investor Relations<\/b>
Cody Slach, Matthew Hausch
\n
Gateway Investor Relations
\n
(949) 574-3860
\n
FOXO@gatewayir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that the Company has filed its Form 10-Q for the third quarter ended September 30, 2022. The company initially delayed its filing of Form … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51214","6":"format-standard","7":"category-industry"},"yoast_head":"\nFOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that the Company has filed its Form 10-Q for the third quarter ended September 30, 2022. The company initially delayed its filing of Form ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-24T00:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022\",\"datePublished\":\"2022-11-24T00:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/\"},\"wordCount\":2411,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005474\\\/en\\\/1646488\\\/21\\\/FOXO-Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/\",\"name\":\"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005474\\\/en\\\/1646488\\\/21\\\/FOXO-Black.jpg\",\"datePublished\":\"2022-11-24T00:02:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005474\\\/en\\\/1646488\\\/21\\\/FOXO-Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221123005474\\\/en\\\/1646488\\\/21\\\/FOXO-Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/","og_locale":"en_US","og_type":"article","og_title":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend","og_description":"MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSEAM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that the Company has filed its Form 10-Q for the third quarter ended September 30, 2022. The company initially delayed its filing of Form ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-24T00:02:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022","datePublished":"2022-11-24T00:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/"},"wordCount":2411,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/","url":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/","name":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg","datePublished":"2022-11-24T00:02:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221123005474\/en\/1646488\/21\/FOXO-Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/foxo-technologies-announces-filing-of-form-10-q-for-the-third-quarter-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51214"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51214\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}